Board Certified Ophthalmologist Agrees to Civil Fraud Settlement in Medicare Fraud Investigation
The United States has entered into an agreement to settle civil fraud claims with Dr. Mark Fleckner, a Board Certified Ophthalmologist who maintains a practice in Garden City, New York. The agreement resolves allegations that, in contravention of Medicare regulations and in violation of the federal False Claims Act, Dr. Fleckner administered certain pharmaceutical products that he had purchased overseas, which the U.S. Food and Drug Administration ("FDA") had not evaluated nor approved for use in the United States ("Unapproved Drugs"). These products included aflibercept ("Eylea") and ranibizumab ("Lucentis"), which Dr. Fleckner used to treat patients who had wet, age-related macular degeneration or other diseases and conditions of the eye. The United States contends that the Unapproved Drugs were not eligible for reimbursement by Medicare. Under the terms of the civil settlement agreement, Dr. Fleckner will pay a total of $6,955,240.80.
- Date:September 24, 2018
- Agency:U.S. Attorney
- Criminal and Civil Actions